Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,168,518 papers from all fields of science
Search
Sign In
Create Free Account
GA 101
Known as:
GA-101
, GA101 antibody
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
RO 5072759
Broader (1)
obinutuzumab
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Effects of Ibrutinib on Rituximab and GA-101 Induced Antibody-Dependent Cell Cytotoxicity (ADCC) in Lymphoma Cells in Vitro
C. Davis
,
Emily Stepanchick
,
+4 authors
S. Balasubramanian
2014
Corpus ID: 76033412
Introduction: Ibrutinib is a first-in-class, oral, once-daily, small molecule that covalently binds to and inhibits Bruton's…
Expand
2012
2012
Przeciwciała monoklonalne w leczeniu przewlekłej białaczki limfocytowej
T. Robak
2012
Corpus ID: 170090569
2011
2011
Biogen Idec restructures, sharpens neurology focus
P. Mitchell
Nature Biotechnology
2011
Corpus ID: 205264959
It seems odd for a company in good financial health to undertake a dramatic restructuring, but Biogen Idec of Weston…
Expand
Review
2010
Review
2010
Novel agents for the treatment of chronic lymphocytic leukemia.
K. Abou-Nassar
,
Jennifer R. Brown
Clinical advances in hematology & oncology : H&O
2010
Corpus ID: 720723
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. Currently, the most effective treatment for…
Expand
Review
2010
Review
2010
How I treat elderly or comorbid patients with chronic lymphocytic leukemia.
L. Smolej
Acta medica
2010
Corpus ID: 28171794
Treatment of chronic lymphocytic leukemia (CLL) has recently undergone several major changes. Most importantly, large randomized…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE